Inspire Sleep Apnea Implant Review
The Inspire Sleep Apnea Implant is a medical device that is implanted into the body for the treating snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive sleep apnea syndrome is a disease caused by relapsing episodes of sleep apnea. It is a condition where breathing stops for a lot more than 10 seconds, during which oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs during sleep, when the muscles of upper airways relax, evoking the obstruction of the respiratory system. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places pressure on the body, causing increased blood circulation pressure and development of severe diseases. The diseases caused by OSA could be physical, such as hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during 1 hour of sleep and determines the severity of the disease. ufabet The apnea index is known as significant if you can find more than 20 apnea episodes each hour, whatever the presence or absence of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many folks think it is uncomfortable to sleep with the mask on the facial skin and the machine itself can be loud, especially as it commonly sits close to the head. Only 25% of patients can use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire ANTI SNORING Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately 10 years.
The main unit of the device is placed under the skin, on leading right side of the chest and it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stand out, and helps maintain the airways open while asleep.
As well as the two electrodes, this device also includes a handy small remote switch, which actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of your day, whenever a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements usually do not cause pain, instead only a minor discomfort. These unpleasant effects disappear following the first few uses of these devices.
Generally, the implant ought to be checked one or two 2 times each year. However, according to the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire Sleep Apnea Implant is only suitable for:
Patients who are a lot more than 22 years old.
Patients who’ve been identified as having moderate or severe obstructive anti snoring syndrome.
Patients with an apnea index in the number of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or did not have the desired effect.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. has shown that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at 24 months following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly use of this therapy for five years. Therefore, it is evident that method is impressive and simple to use!